NIAGEN BIOSCIENCE, INC. Increase (Decrease) in Contract with Customer, Liability
NIAGEN BIOSCIENCE, INC. (NAGE) reported Increase (Decrease) in Contract with Customer, Liability of -$240.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInContractWithCustomerLiability · last filed 2026-08-04
- NIAGEN BIOSCIENCE, INC. increase (decrease) in contract with customer, liability for the quarter ending 2026-06-30 was -$138.00K, a 245.26% decline year-over-year.
- NIAGEN BIOSCIENCE, INC. increase (decrease) in contract with customer, liability for the quarter ending 2026-03-31 was -$102.00K.
- NIAGEN BIOSCIENCE, INC. increase (decrease) in contract with customer, liability for the quarter ending 2025-12-31 was $0.00.
- NIAGEN BIOSCIENCE, INC. increase (decrease) in contract with customer, liability for the quarter ending 2025-09-30 was $0.00.
- NIAGEN BIOSCIENCE, INC. increase (decrease) in contract with customer, liability for fiscal 2025 was $95.00K.
- NIAGEN BIOSCIENCE, INC. increase (decrease) in contract with customer, liability for fiscal 2024 was -$732.00K.
- NIAGEN BIOSCIENCE, INC. increase (decrease) in contract with customer, liability for fiscal 2023 was -$644.00K.
- NIAGEN BIOSCIENCE, INC. increase (decrease) in contract with customer, liability for fiscal 2022 was -$391.00K.
| Period end | Increase (Decrease) in Contract with Customer, Liability 3 month | Increase (Decrease) in Contract with Customer, Liability 6 month | Increase (Decrease) in Contract with Customer, Liability 9 month | Increase (Decrease) in Contract with Customer, Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$138.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | -$240.00K 10-Q · filed 2026-08-04 | -$240.00K derived: sum of 3 quarters · filed 2026-08-04 | -$240.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | -$102.00K 10-Q · filed 2026-05-06 | -$102.00K derived: sum of 2 quarters · filed 2026-05-06 | -$102.00K derived: sum of 3 quarters · filed 2026-05-06 | -$7.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $0.00 derived: sum of 2 quarters · filed 2026-03-04 | $95.00K derived: sum of 3 quarters · filed 2026-08-04 | $95.00K 10-K · filed 2026-03-04 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $95.00K derived: sum of 2 quarters · filed 2026-08-04 | $95.00K 10-Q · filed 2025-11-04 | $95.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $95.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $95.00K 10-Q · filed 2026-08-04 | $95.00K derived: sum of 3 quarters · filed 2026-08-04 | -$637.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-06 | $0.00 derived: sum of 2 quarters · filed 2026-05-06 | -$732.00K derived: sum of 3 quarters · filed 2026-05-06 | |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | -$732.00K derived: sum of 2 quarters · filed 2026-03-04 | -$732.00K 10-K · filed 2026-03-04 | |
| 2024-09-30 | -$732.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$732.00K 10-Q · filed 2025-11-04 | ||
| 2024-06-30 | $0.00 10-Q · filed 2025-08-06 | |||
| 2023-12-31 | -$495.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | -$495.00K derived: sum of 2 quarters · filed 2025-03-04 | -$644.00K 10-K · filed 2025-03-04 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | -$149.00K 10-Q · filed 2024-10-31 | ||
| 2023-06-30 | -$149.00K 10-Q · filed 2024-08-07 | |||
| 2022-12-31 | -$273.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-06 | -$273.00K derived: sum of 2 quarters · filed 2024-03-06 | -$391.00K 10-K · filed 2024-03-06 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$118.00K 10-Q · filed 2023-11-08 | ||
| 2022-06-30 | -$118.00K 10-Q · filed 2023-08-09 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-08 | -$95.00K derived: sum of 2 quarters · filed 2023-03-08 | -$95.00K 10-K · filed 2023-03-08 | |
| 2021-09-30 | -$95.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | -$95.00K 10-Q · filed 2022-11-02 | ||
| 2021-06-30 | $0.00 10-Q · filed 2022-08-10 | |||
| 2020-12-31 | $621.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-14 | $621.00K derived: sum of 2 quarters · filed 2022-03-14 | $568.00K 10-K · filed 2022-03-14 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | -$53.00K 10-Q · filed 2021-11-03 | ||
| 2020-06-30 | -$53.00K 10-Q · filed 2021-08-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |